Radiopharmaceuticals
Ended Awarded Last action
- Contract number
- 36C25724N0432
- Awardee
-
RLS (USA) Inc. UEI UA3GDUKRYSM5
- Awarding agency
-
Veterans Integrated Service Network 17
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $822,868
Award facts
- Opportunity
-
- 6505--Radiopharmaceuticals (CTX) Solicitation · Posted Jun 21, 2024
- Contract value 100% obligated
- $822,867.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Lake Mary, FL 32746, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$158,777 | |
| Original award | $981,645 |
About this award
The Department of Veterans Affairs (VA) Veterans Integrated Service Network 17 (VISN 17) awarded a $822,867.94 firm fixed-price delivery order to RLS (USA) Inc. for radiopharmaceutical products, effective September 18, 2024, with an ultimate completion date of September 18, 2025. This delivery order represents a task order issued under RLS (USA) Inc.'s larger Indefinite Delivery Contract (IDC) with VA VISN 17, which carries a ceiling value of approximately $5 million and extends through September 2029. The award includes de-obligated excess funds, indicating a modification to reallocate resources from a prior delivery order. The contract carries no set-aside designation and is structured as a firm fixed-price procurement, enabling the Central Texas Veterans Health Care System and associated VA facilities to obtain specialized nuclear medicine diagnostic imaging agents on an as-needed basis without requiring separate competitive procurements.
RLS (USA) Inc., a foreign-owned radiopharmacy company headquartered in Lake Mary, Florida, operates 31 facilities across 18 states and serves as a critical supplier of radiopharmaceutical products to the VA and Defense Health Agency. The company's comprehensive product portfolio includes standard medical isotopes such as technetium-99m and fluorodeoxyglucose F-18, as well as specialized diagnostic and therapeutic agents including Gallium-68 Dotatate (NETSPOT) and locametz. This delivery order supports VA VISN 17's nuclear medicine diagnostic and therapeutic procedures, contributing to the network's clinical operations across multiple medical centers throughout Central Texas. RLS (USA) Inc. maintains an extensive portfolio of federal IDVs and blanket purchase agreements valued at over $17 million across multiple VA VISN networks and the Defense Health Agency, establishing the company as a preferred supplier for time-sensitive radiopharmaceutical procurement throughout the federal healthcare enterprise.
Quick answers
Who was awarded contract 36C25724N0432?
36C25724N0432 was awarded to RLS (USA) Inc. by Veterans Integrated Service Network 17 (Veterans Health Administration) on September 18, 2024.
How much is contract 36C25724N0432 worth?
The government has obligated $822,868 on 36C25724N0432.
Is contract 36C25724N0432 an order under another contract?
Yes. 36C25724N0432 is a delivery order under 36C25724D0080, an indefinite delivery contract.
Was contract 36C25724N0432 competed?
The extent of competition for 36C25724N0432 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award